RTI Surgical Holdings Inc

RTI Surgical — Regeneration Technologies — Stephens Fall Investment Conference 2007

27 slides from RTI Surgical's conference presentation, Nov 15, 2007

  1. Slide 1: Tutogen Medical, Inc. Stephens Fall Investment Conference

    Tutogen Medical, Inc. Stephens Fall Investment Conference November 14, 2007 AMEX: TTG

  2. Slide 2: Forward Looking Statement

    FORWARD LOOKING STATEMENT This communication contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include but are not limited to statements about the expected benefits of the business combination involving Regeneration Tech

  3. Slide 3: Additional information about the proposed merger

    The proposed merger will be submitted to the respective stockholders of Regeneration Technologies and Tutogen for their consideration, and Regeneration Technologies and Tutogen will file a registration statement, a joint proxy statement/prospectus and other relevant documents concerning the proposed

  4. Slide 4: Merger Announcement

    MERGER ANNOUNCEMENT On November 13, 2007, Regeneration Technologies, Inc. and Tutogen Medical, Inc. announced a merger to create the leading provider of sterile biologic solutions for patients around the world, reaching a broad range of markets and medical specialties with a diversified mix of impla

  5. Slide 5: Combined Leadership

    COMBINED LEADERSHIP Executive Leadership: Brian Hutchison, Chairman and CEO Guy Mayer, President focused on international activities and sales and marketing Tom Rose, VP, CFO and Secretary Bob Johnston, VP Finance Board of Directors: Total of 12 directors Seven directors from RTI board, including Hu

  6. Slide 6: Implant Segments

    IMPLANT SEGMENTS Int'l Spine Sports Med Other R - Products 0.06 0.43 0.25 0.26 Int'l Dent. Spine Other T - Products 0.28 0.48 0.1 0.14 Other Spine Sports Med Dental Int'l BGS Surgical Spec Pro Forma 6 32 16 17 14 10 5 + RTI Tutogen Combined Company

  7. Slide 7: Combined Implant Segments

    COMBINED IMPLANT SEGMENTS RTI Tutogen Combined Spine ? ? ? Sports Medicine ? ? Bone Graft Substitutes ? ? General Orthopedic ? ? Other ? ? Dental ? ? Urology ? ? Hernia ? ? Ophthalmology ? ? Breast Reconstruction ? ? ENT ? ? International ? ?

  8. Slide 8: Key Distributors

    KEY DISTRIBUTORS Int'l MSD Other ZMH Pro Forma 14 37 27 22 Int'l MSD Other R - Dist. 0.06 0.6 0.34 Int'l ZMH Other T - Distribution 0.28 0.58 0.14 + RTI Tutogen Combined Company

  9. Slide 9: Combined Financial Highlights

    COMBINED FINANCIAL HIGHLIGHTS >$30 million in cash at Dec. 31, 2007 and generate positive operating cash flow Strong balance sheet with very little debt Accretive to RTI's 2008 GAAP earnings per share $5-6MM of identified 2008 cost savings when fully implemented Significant revenue enhancement oppor

  10. Slide 10: Company Overview

    Tutogen is a leading worldwide manufacturer and supplier of sterile biological implants made from human (allograft) and animal (xenograft) soft tissue and bone The Company is the only biologics manufacturer worldwide able to claim a 100% sterile full product complement using the Company's Tutoplast

  11. Slide 11: Tutoplast Process Production Flow

    Tutoplast(r) Process Production Flow DELIPIDIZATION OSMOTIC TREATMENT OXIDATIVE TREATMENT DEHYDRATION TISSUE DONATION PRECISION MACHINING STERILIZATION INCOMING INSPECTION PACKAGING Multi-step Process Substantially eliminates all types of pathogens More than 1.5 million grafts implanted With an unbl

  12. Slide 12: Advantages of Tutoplast Process

    Advantages of Tutoplast Process Inactivates and removes bacteria Removes lipids Inactivates prion activity Removes antigenicity Eliminates viral infectivity by a safety margin of 5 log (100,000 times) Breaks down RNA and DNA into fragments not capable of replication and disease transmission Preserve

  13. Slide 13: U.S. Market Size: $1.25 Billion

    U.S. Market Size: $1.25 Billion* Addressable Markets Hernia 150 Spine 656 Dental 169 Surgical Specialty 279 Urology Obstetrics/Gynecology Breast Reconstruction Ophthalmology Ear Nose & Throat (ENT) *Source: Internal Estimates and Orthopedic Network News, October 2005

  14. Slide 14: Partnership: Zimmer Dental

    Partnership Zimmer Dental, Inc. - subsidiary of Zimmer Holdings (NYSE: ZMH) Valued partner since Sept. 2000 Worldwide New Agreement Completed August 2007 Products and Applications Puros Block Allograft increases bone volume for surgical ridge augmentation Puros Cortical Particulate Allograft provide

  15. Slide 15: U.S. Quarterly Dental Sales

    U.S. Quarterly Dental Sales (Jan. 2002 to June 2007) Dental Q2 2002 401.8 Q3 2002 502 Q4 2002 434.3 Q1 2003 772.8 Q2 2003 903.3 Q3 2003 1010.5 Q4 2003 1033.3 Q1 2004 1389.6 Q2 2004 1633.2 Q3 2004 1873.5 Q4 2004 1996.5 Q1 2005 2598.9 Q2 2005 3102.1 Q3 2005 3968.9 Q4 2005 4214.9 Q1 2006 3884.7 Q2 2006

  16. Slide 16: Dental Accounts Growth - Past Months

    Dental Accounts Growth - Past 12 Months Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May June 121 156 187 190 207 125 193 186 233 181 201 194

  17. Slide 17: International Dental Opportunity

    International Dental Opportunity Total Market-$180 million Several regulatory approvals already in place Exclusive Distributorship in over 30 countries including Germany-large dental implant market-large potential Full line of allograft and xenograft products to promote bone growth for dental implan

  18. Slide 18: Spine Market

    Spine Market Estimated 2005 U.S. Machined Bone Market $321 Million, 18% growth* Estimated percent of time bone is used in Spinal fusion procedures ALIF - 12% Cervical - 68% PLIF - 72% TLIF - 9% Current Focus on Machined Bone New Products shipped to Zimmer Puros C for Cervical procedures Puros A for

  19. Slide 19: Partnership: Zimmer Spine

    Partnership Zimmer Spine, Inc. - subsidiary of Zimmer Holdings (NYSE: ZMH) Valued partner since Sept. 2000 U.S. & Canada Products and Applications Puros Bone for enhancing interbody fusion Traditional bone Specialty Machined grafts Cervical Grafts, ALIF and PLIF Initiatives First new products design

  20. Slide 20: Partnership: Davol (Hernia Market)

    NEW Partnership Davol Inc. - subsidiary of CR Bard, Inc. (NYSE: BCR) Market leader (60%) in estimated $500 million worldwide market Products and Applications Repair of hernias and reconstruction of the chest and abdominal walls AlloMax-human dermis product Initiatives Training sales force Product re

  21. Slide 21: Breast Reconstruction Partnership: Mentor

    Breast Reconstruction NEW Partnership Mentor Corporation (NYSE: MNT) Market leader in Breast Implants Applications and Products Breast Reconstruction following Mastectomy NeoForm(tm) Human Dermis Initiatives Training sales force Product introduced in 2nd Quarter to clinical sites Product launched Ju

  22. Slide 22: International Business

    International Business Dental Tissue Service Membranes Orthopaedic Sports Medicine 2006 extr 16 10 36 35 3 Distributor Based Sales 60% Membranes / 40% Bone 65% Human / 35% Bovine Strategy Driving Global Agreements Davol Hernia Repair Signed January 2006 Coloplast Agreement in Urology/Gynecology Sign

  23. Slide 23: Bovine Initiatives

    Bovine Initiatives 30%-35% of international sales are bovine products Tutogen to introduce bovine pericardium product to U.S. marketplace through Zimmer Dental-January 2008 Tutogen to introduce bovine pericardium product for hernia repair in U.S. to initial clinical sites over the next 12 months Col

  24. Slide 24: Revenues for Nine Months Ended June 30, 2007 and 2006

    Revenues for Nine Months Ended June 30, 2007 and 2006 (in 000's)

  25. Slide 25: Quarterly Financials

    Quarterly Financials Sep. '06 Dec. '06 Mar. '07 June '07 Revenue 10.798 11.5 13 14.2 Sept. '06 Dec. '06 Mar. 07 6/7/2007 EPS 0.599 0.361 0.93 0.9 Revenue Net Income $ Millions $ Millions

  26. Slide 26: Balance Sheet as of June 30, 2007

    Balance Sheet as of June 30, 2007

  27. Slide 27: Tutogen Medical, Inc. Stephens Fall Investment Conference

    Tutogen Medical, Inc. Stephens Fall Investment Conference November 14, 2007 AMEX: TTG

Regeneration Technologies — Stephens Fall Investment Conference 2007 on 6ix